ZYBT Financial Model

Quarterly and annual income statement, cash flow and balance sheet line items for Zhengye Biotechnology Holding Limited Ordinary Shares: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding. Latest statement: Mar 31, 2026.

ZYBT – Zhengye Biotechnology Holding Limited Ordinary Shares stock overview